Anders Johnsson

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2019
  2. Physical activity and survival following breast cancer

    Anna Johnsson, Per Broberg, Krüger, U., Anders Johnsson, Åsa Tornberg & Håkan Olsson, 2019 mar 21, I : European Journal of Cancer Care. e13037.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. Determinants for local tumour control probability after radiotherapy of anal cancer

    Anders Johnsson, Otilia Leon, Gunnlaugsson, A., Per Nilsson & Peter Höglund, 2018, I : Radiotherapy and Oncology. 128, 2, s. 380-386

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2017
  6. Swelling and mass transport properties of nanocellulose-HPMC composite films

    Mikael Larsson, Anders Johnsson, Gårdebjer, S., Bordes, R. & Larsson, A., 2017 maj 15, I : Materials and Design. 122, s. 414-421 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Occupational sedentariness and breast cancer risk

    Anna Johnsson, Per Broberg, Anders Johnsson, Åsa B. Tornberg & Håkan Olsson, 2017, I : Acta Oncologica. 56, 1, s. 75-80 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2016
  9. Drug costs and benefits of medical treatments in high-unmet need solid tumours in the Nordic countries

    Osterlund, P., Sorbye, H., Pfeiffer, P., Anders Johnsson, Rodrigues, F. & Furneri, G., 2016 mar 1, I : Journal of Cancer Policy. 7, s. 12-22 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

    Helga Hagman, Frödin, J-E., Berglund, Å., Sundberg, J., Vestermark, L., Albertsson, M., Fernebro, E. & Anders Johnsson, 2016 jan, I : Annals of Oncology. 27, 1, s. 140-147

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2015
  12. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.

    Otilia Leon, Guren, M. G., Radu, C., Gunnlaugsson, A. & Anders Johnsson, 2015, I : European Journal of Cancer. 51, 18, s. 2740-2746

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2014
  14. Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.

    Otilia Leon, Guren, M., Oskar Hagberg, Glimelius, B., Dahl, O., Havsteen, H., Naucler, G., Svensson, C., Tveit, K. M., Jakobsen, A., Pfeiffer, P., Wanderås, E., Ekman, T., Lindh, B., Balteskard, L., Frykholm, G. & Anders Johnsson, 2014, I : Radiotherapy and Oncology. 113, 3, s. 352-358

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Epidermal Growth Factor-like Domain 7 Predicts Response to First-Line Chemotherapy and Bevacizumab in Patients with Metastatic Colorectal Cancer.

    Hansen, T. F., Nielsen, B. S., Sørensen, F. B., Anders Johnsson & Jakobsen, A., 2014, I : Molecular Cancer Therapeutics. 13, 9, s. 2238-2245

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2013
  17. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

    Anders Johnsson, Helga Hagman, Frödin, J-E., Berglund, Å., Keldsen, N., Fernebro, E., Sundberg, J., De Pont Christensen, R., Garm Spindler, K-L., Bergström, D. & Jakobsen, A., 2013, I : Annals of Oncology. 24, 9, s. 2335-2341

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial

    Hansen, T. F., Christensen, R. D., Andersen, R. F., Sorensen, F. B., Anders Johnsson & Jakobsen, A., 2013, I : British Journal of Cancer. 109, 5, s. 1243-1251

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Physical activity during and after adjuvant chemotherapy in patients with breast cancer.

    Johnsson, A., Anders Johnsson & Karin Johansson, 2013, I : Physiotherapy. 99, 3, s. 221-227

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2012
  21. Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.

    Oshima, G., Johan Wennerberg, Yamatodani, T., Kjellén, E., Mineta, H., Anders Johnsson & Lars Ekblad, 2012, I : Journal of Cancer Research and Clinical Oncology. 138, 3, s. 491-499

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer.

    Lars Ekblad & Anders Johnsson, 2012, I : Anticancer research. 32, 3, s. 783-786

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.

    Tveit, K. M., Guren, T., Glimelius, B., Pfeiffer, P., Sorbye, H., Pyrhonen, S., Sigurdsson, F., Kure, E., Ikdahl, T., Skovlund, E., Fokstuen, T., Hansen, F., Hofsli, E., Birkemeyer, E., Johnsson, A., Starkhammar, H., Yilmaz, M. K., Keldsen, N., Erdal, A. B., Dajani, O. & 2 andraDahl, O. & Christoffersen, T., 2012, I : Journal of Clinical Oncology. 30, 15, s. 1755-1762

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts

    Yamatodani, T., Holmqvist, B., Kjellén, E., Anders Johnsson, Mineta, H. & Johan Wennerberg, 2012, I : Acta Oto-Laryngologica. 132, 12, s. 1324-1333

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2011
  26. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

    Anna H Larsson, Martin Johansson, Wangefjord, S., Gaber, A., Björn Nodin, Kucharzewska, P., Charlotte Welinder, Mattias Belting, Jakob Eberhard, Anders Johnsson, Uhlen, M. & Karin Jirström, 2011, I : British Journal of Cancer. 105, 5, s. 666-672

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2010
  28. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

    Gunnlaugsson, A., Anderson, H., Lind, P., Glimelius, B. & Anders Johnsson, 2010, I : Radiotherapy and Oncology. 95, 3, s. 292-297

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

    Gubanski, M., Anders Johnsson, Fernebro, E., Kadar, L., Karlberg, I., Flygare, P., Berglund, A., Glimelius, B. & Lind, P. A., 2010, I : Gastric Cancer. 13, 3, s. 155-161

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2009
  31. Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.

    Gunnlaugsson, A., Anderson, H., Fernebro, E., Kjellén, E., Byström, P., Berglund, K., Ekelund, M., Påhlman, L., Holm, T., Glimelius, B. & Anders Johnsson, 2009, I : European Journal of Cancer. 45, s. 807-813

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.

    Gunnlaugsson, A., Per Nilsson, Kjellén, E. & Anders Johnsson, 2009, I : Radiation Oncology. 4, Dec 9, 61.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. 2008
  34. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma

    Lind, PA., Isaksson, B., Almstrom, M., Anders Johnsson, Albiin, N., Bystrom, P. & Permert, J., 2008, I : Acta Oncologica. 47, 3, s. 413-420

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. How does light affect melatonin?

    Lars Olof Björn & Anders Johnsson, 2008, I : Medical Hypotheses. Jun 4, s. 458-458

    Forskningsoutput: TidskriftsbidragLetter

  36. 2007
  37. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer

    Gunnlaugsson, A., Kjellén, E., Per Nilsson, Pär-Ola Bendahl, Willner, J. & Anders Johnsson, 2007, I : Acta Oncologica. 46, 7, s. 937-944

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2006
  39. Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin ((191)pt) in wistar rats.

    Norrgren, K., Sjölin, M., Bjorkman, S., Areberg, J., Anders Johnsson, Johansson, L. & Sören Mattsson, 2006, I : Cancer Biotherapy & Radiopharmaceuticals. 21, 5, s. 528-534

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2005
  41. Gene expression profiling in chemoresistant variants of three cell lines of different origin.

    Anders Johnsson, Johan Vallon-Christersson, Carina Forsare, Litman, T. & Eriksen, J., 2005, I : Anticancer research. 25, 4, s. 2661-2668

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.

    Kjellström, J., Kjellén, E. & Anders Johnsson, 2005, I : Acta Oncologica. 44, 7, s. 687-693

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. 2001
  44. Antitumor effect of radioactive cisplatin (191Pt) on nude mice

    Areberg, J., Johan Wennerberg, Anders Johnsson, Norrgren, K. & Sören Mattsson, 2001, I : International Journal of Radiation Oncology, Biology, Physics. 49, 3, s. 827-832

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. 1996
  46. Pharmacokinetic and pharmacodynamic studies on cisplatin in mice and men

    Anders Johnsson, 1996, Anders Johnsson MD, Dept of Oncology, University Hospital, S-21 85 Lund, Sweden,. 110 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)